A new trading day began on Monday, with Avidity Biosciences Inc (NASDAQ: RNA) stock price up 3.02% from the previous day of trading, before settling in for the closing price of $30.50. RNA’s price has ranged from $8.95 to $56.00 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 58.16%. Meanwhile, its annual earnings per share averaged 1.48%. With a float of $108.55 million, this company’s outstanding shares have now reached $118.90 million.
The extent of productivity of a business whose workforce counts for 253 workers is very important to gauge. In terms of profitability, gross margin is 80.79%, operating margin of -3209.35%, and the pretax margin is -2772.45%.
Avidity Biosciences Inc (RNA) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Avidity Biosciences Inc is 9.02%, while institutional ownership is 101.12%. The most recent insider transaction that took place on Dec 18 ’24, was worth 416,154. In this transaction CSTO of this company sold 12,742 shares at a rate of $32.66, taking the stock ownership to the 72,647 shares. Before that another transaction happened on Dec 18 ’24, when Company’s Chief Financial Officer sold 11,151 for $32.66, making the entire transaction worth $364,192. This insider now owns 82,942 shares in total.
Avidity Biosciences Inc (RNA) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 1.48% per share during the next fiscal year.
Avidity Biosciences Inc (NASDAQ: RNA) Trading Performance Indicators
Here are Avidity Biosciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 17.76. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 370.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.90, a number that is poised to hit -0.79 in the next quarter and is forecasted to reach -3.21 in one year’s time.
Technical Analysis of Avidity Biosciences Inc (RNA)
The latest stats from [Avidity Biosciences Inc, RNA] show that its last 5-days average volume of 1.21 million was superior to 1.02 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 63.70%. Additionally, its Average True Range was 2.07.
During the past 100 days, Avidity Biosciences Inc’s (RNA) raw stochastic average was set at 11.20%, which indicates a significant decrease from 51.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 50.90% in the past 14 days, which was lower than the 62.57% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $39.40, while its 200-day Moving Average is $37.49. Now, the first resistance to watch is $32.57. This is followed by the second major resistance level at $33.73. The third major resistance level sits at $34.95. If the price goes on to break the first support level at $30.19, it is likely to go to the next support level at $28.97. The third support level lies at $27.81 if the price breaches the second support level.
Avidity Biosciences Inc (NASDAQ: RNA) Key Stats
With a market capitalization of 3.75 billion, the company has a total of 119,309K Shares Outstanding. Currently, annual sales are 9,560 K while annual income is -212,220 K. The company’s previous quarter sales were 2,340 K while its latest quarter income was -80,400 K.
